ArticleWorld journal of gastroenterology2025
Exploring the performance of large language models on hepatitis B infection-related questions: A comparative study.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Application of Large Language Models in Chronic Disease Care: Mixed Methods Systematic Review and Thematic Synthesis.Journal of medical Internet research · 2026Pooled it
- Comparison of the readability of ChatGPT and Bard in medical communication: a meta-analysis.BMC medical informatics and decision making · 2025Pooled it
- Evaluating the Performance of Large Language Models for Breast Cancer Patient Education: A Comparative Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
- Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review.Health science reports · 2026Review
- Large Language Models in Infectious Diseases: A Systemic Review.Research square · 2026Article
- Hepatitis C Patient Education: Large Language Models Show Promise in Disseminating Guidelines.Journal of clinical and translational hepatology · 2026Article
- Article
- The application and challenges of ChatGPT in laboratory medicine.Advances in laboratory medicine · 2025Review
- Evaluating the Role of Artificial Intelligence in Making Clinical Decisions for Treating Acute Pancreatitis.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with hepatitis B virus (HBV) infection require chronic and personalized care to improve outcomes. Large language models (LLMs) can potentially provide medical information for patients.
aimTo examine the performance of three LLMs, ChatGPT-3.5, ChatGPT-4.0, and Google Gemini, in answering HBV-related questions.
methodsLLMs' responses to HBV-related questions were independently graded by two medical professionals using a four-point accuracy scale, and disagreements were resolved by a third reviewer. Each question was run three times using three LLMs. Readability was assessed
resultsOverall, all three LLM chatbots achieved high average accuracy scores for subjective questions (ChatGPT-3.5: 3.50; ChatGPT-4.0: 3.69; Google Gemini: 3.53, out of a maximum score of 4). With respect to objective questions, ChatGPT-4.0 achieved an 80.8% accuracy rate, compared with 62.9% for ChatGPT-3.5 and 73.1% for Google Gemini. Across the six domains, ChatGPT-4.0 performed better in terms of diagnosis, whereas Google Gemini demonstrated excellent clinical manifestations. Notably, in the readability analysis, the mean Gunning Fog index and Flesch-Kincaid grade level scores of the three LLM chatbots were significantly higher than the standard level eight, far exceeding the reading level of the normal population.
conclusionOur results highlight the potential of LLMs, especially ChatGPT-4.0, for delivering responses to HBV-related questions. LLMs may be an adjunctive informational tool for patients and physicians to improve outcomes. Nevertheless, current LLMs should not replace personalized treatment recommendations from physicians in the management of HBV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.